LT5069B - Priešvėžinio vaisto stabili farmacinė forma ir jos gamybos būdas - Google Patents

Priešvėžinio vaisto stabili farmacinė forma ir jos gamybos būdas Download PDF

Info

Publication number
LT5069B
LT5069B LT2003031A LT2003031A LT5069B LT 5069 B LT5069 B LT 5069B LT 2003031 A LT2003031 A LT 2003031A LT 2003031 A LT2003031 A LT 2003031A LT 5069 B LT5069 B LT 5069B
Authority
LT
Lithuania
Prior art keywords
solvents
paclitaxel
water
pharmaceutical form
mixture
Prior art date
Application number
LT2003031A
Other languages
English (en)
Lithuanian (lt)
Other versions
LT2003031A (en
Inventor
Stanislaw Janicki
Malgorzata Sznitowska
Wladyslaw Karas
Zdislaw Mroczek
Andrzej Tyrala
Iwona Czarnecka
Original Assignee
Warszawskie Zaklady Farmaceutyczne "Polfa" Spolka Akcyjna
Instytut Chemii Organicznej Pan
Akademia Medyczna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warszawskie Zaklady Farmaceutyczne "Polfa" Spolka Akcyjna, Instytut Chemii Organicznej Pan, Akademia Medyczna filed Critical Warszawskie Zaklady Farmaceutyczne "Polfa" Spolka Akcyjna
Publication of LT2003031A publication Critical patent/LT2003031A/xx
Publication of LT5069B publication Critical patent/LT5069B/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
LT2003031A 2000-10-31 2003-05-05 Priešvėžinio vaisto stabili farmacinė forma ir jos gamybos būdas LT5069B (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL343615A PL203300B1 (pl) 2000-10-31 2000-10-31 Stabilna postać farmaceutyczna leku przeciwnowotworowego oraz sposób wytwarzania stabilnej postaci farmaceutycznej leku przeciwnowotworowego

Publications (2)

Publication Number Publication Date
LT2003031A LT2003031A (en) 2003-09-25
LT5069B true LT5069B (lt) 2003-11-25

Family

ID=20077651

Family Applications (1)

Application Number Title Priority Date Filing Date
LT2003031A LT5069B (lt) 2000-10-31 2003-05-05 Priešvėžinio vaisto stabili farmacinė forma ir jos gamybos būdas

Country Status (15)

Country Link
EP (1) EP1363892B1 (pl)
AU (1) AU2002212863A1 (pl)
BG (1) BG65985B1 (pl)
CZ (1) CZ300836B6 (pl)
DE (1) DE60122384T2 (pl)
HK (1) HK1060733A1 (pl)
HU (1) HUP0303089A3 (pl)
LT (1) LT5069B (pl)
PL (1) PL203300B1 (pl)
RU (1) RU2236227C1 (pl)
SI (1) SI21138B (pl)
SK (1) SK287850B6 (pl)
UA (1) UA75620C2 (pl)
WO (1) WO2002036582A1 (pl)
ZA (1) ZA200303276B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04005038A (es) * 2001-11-30 2004-08-11 Bristol Myers Squibb Co Solvatos de paclitaxel.
PT1694660E (pt) 2003-12-12 2009-07-16 Quiral Quimica Do Brasil Processo de preparação de ingredientes farmacêuticos activos (api) anidros e hidratados; composições farmacêuticas estáveis preparadas a partir dos mesmos e utilizações das referidas composições
AR054215A1 (es) * 2006-01-20 2007-06-13 Eriochem Sa Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
CA2683712A1 (en) * 2007-04-20 2009-01-15 Sun Pharmaceutical Industries Limited Pharmaceutical compositions
CN110437179A (zh) * 2019-08-22 2019-11-12 江苏红豆杉药业有限公司 一种紫杉醇单晶晶体及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL169372B1 (en) 1991-07-08 1996-07-31 Rhone Poulenc Rorer Sa Method of obtaining a pharmaceutical composition containing novel derivative of taxames group
PL176826B1 (pl) 1993-09-29 1999-07-30 Bristol Myers Squibb Co Stabilizowana kompozycja przeciwnowotworowa i sposób wytwarzania stabilizowanej kompozycji przeciwnowotworowej

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2163837C (en) * 1994-12-13 1999-07-20 Robert K. Perrone Crystalline paclitaxel hydrates

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL169372B1 (en) 1991-07-08 1996-07-31 Rhone Poulenc Rorer Sa Method of obtaining a pharmaceutical composition containing novel derivative of taxames group
PL176826B1 (pl) 1993-09-29 1999-07-30 Bristol Myers Squibb Co Stabilizowana kompozycja przeciwnowotworowa i sposób wytwarzania stabilizowanej kompozycji przeciwnowotworowej

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ROWINSKY EK, CAZENAVE LA, DONEHOWER RC.: "Taxol: a novel investigational antimicrotubule agent", J NATL CANCER INST., 1990, pages 1247 - 1259, XP002054343, DOI: doi:10.1093/jnci/82.15.1247
SLICHENMYER WJ, VON HOFF DD.: "New natural products in cancer chemotherapy", J. CLIN. PHARMACOL., 1990, pages 770 - 788

Also Published As

Publication number Publication date
HUP0303089A2 (hu) 2003-12-29
HK1060733A1 (en) 2004-08-20
CZ300836B6 (cs) 2009-08-19
CZ20031421A3 (cs) 2004-06-16
SI21138B (sl) 2006-10-31
DE60122384T2 (de) 2007-08-16
EP1363892B1 (en) 2006-08-16
ZA200303276B (en) 2004-04-21
SK287850B6 (sk) 2012-01-04
HUP0303089A3 (en) 2005-02-28
DE60122384D1 (de) 2006-09-28
BG65985B1 (bg) 2010-08-31
PL343615A1 (en) 2002-05-06
EP1363892A1 (en) 2003-11-26
WO2002036582A1 (en) 2002-05-10
PL203300B1 (pl) 2009-09-30
BG107764A (bg) 2004-07-30
AU2002212863A1 (en) 2002-05-15
UA75620C2 (en) 2006-05-15
SK6292003A3 (en) 2004-08-03
RU2236227C1 (ru) 2004-09-20
SI21138A (sl) 2003-08-31
LT2003031A (en) 2003-09-25

Similar Documents

Publication Publication Date Title
RU2144356C1 (ru) Композиция для инъекций на основе таксоидов
RU2429837C2 (ru) Фармацевтический состав таксана, твердая композиция таксана, способ получения твердой композиции таксана, композиция для солюбилизации указанной твердой композиции таксана и комплект элементов (набор) для состава таксана для инъекций
SK287487B6 (sk) Lyofilizovaná kompozícia a rekonštituovaná lyofilizovaná kompozícia
US5616588A (en) Rapamycin formulation for IV injection
HU217839B (hu) Eljárások taxánszármazékokat tartalmazó új stabil gyógyszerkészítmények előállítására
KR20140067034A (ko) 카바지탁셀 제제와 이를 제조하는 방법
KR20100023862A (ko) 트윈 80을 함유하지 않은 도세탁셀의 용해 제제
EA002776B1 (ru) Фармацевтические композиции, содержащие циклодекстрины и таксоиды
JP2012167132A (ja) Ｎ−［ｏ−（ｐ−ピバロイルオキシベンゼンスルホニルアミノ）ベンゾイル］グリシン・モノナトリウム塩・４水和物の凍結乾燥製剤
CZ298581B6 (cs) Farmaceuticky stabilní prípravek oxaliplatiny k parenterální aplikaci
KR100785603B1 (ko) 치환된 벤즈이미다졸의 제제
EA016619B1 (ru) Новые композиции на основе таксоидов
LT5069B (lt) Priešvėžinio vaisto stabili farmacinė forma ir jos gamybos būdas
BR112021011495A2 (pt) Preparação incluindo adjuvante para vacina
JP2011529930A (ja) 注射可能タキサン医薬品組成物
JP3584064B2 (ja) 静脈注射用ラパマイシン製剤
CA3073527A1 (en) Metolazone emulsion formulation
WO2024095053A1 (en) Novel non-oral formulations of factor xa inhibitors and process for preparation thereof

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20121019